generic raloxifene gets tentative us approval

1
Inpharma 1635 - 26 Apr 2008 Generic raloxifene gets tentative US approval. The US FDA has granted tentative approval to Teva Pharmaceutical Industries’ Abbreviated New Drug Application for raloxifene 60mg tablets. This product is bioequivalent to Lilly’s Evista tablets for osteoporosis, which had sales of approximately $US691 million in the US for the year 2007. Teva is currently involved in patent litigation over this product in the US. Teva Pharmaceutical Industries Ltd. Teva Announces Tentative Approval of Generic Evista (Rm) Tablets. Media Release : 18 Apr 2008. Available from: URL: http://www.tevapharm.com 809087694 1 Inpharma 26 Apr 2008 No. 1635 1173-8324/10/1635-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Post on 11-Dec-2016

213 views

Category:

Documents


1 download

TRANSCRIPT

Inpharma 1635 - 26 Apr 2008

■ Generic raloxifene gets tentative US approval. TheUS FDA has granted tentative approval to TevaPharmaceutical Industries’ Abbreviated New DrugApplication for raloxifene 60mg tablets. This product isbioequivalent to Lilly’s Evista tablets for osteoporosis,which had sales of approximately $US691 million inthe US for the year 2007. Teva is currently involved inpatent litigation over this product in the US.Teva Pharmaceutical Industries Ltd. Teva Announces Tentative Approval ofGeneric Evista (Rm) Tablets. Media Release : 18 Apr 2008. Available from:URL: http://www.tevapharm.com 809087694

1

Inpharma 26 Apr 2008 No. 16351173-8324/10/1635-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved